Einstein-Rockefeller-CUNY Center for AIDS Research

Patient & Population Health Outcome Research

The Patient and Population Health Outcomes Research (PPHOR) Scientific Working Group (SWG) directed by Drs. Denis Nash and Julia Arnsten is focused on identifying strategies to optimize the ‘real world’ impact of efficacious interventions on HIV prevention and care continuum outcomes, including maximizing uptake of pre- and post-exposure prophylaxis (PrEP and nPEP) to minimize HIV acquisition, and improving the timeliness of diagnosis and treatment initiation, to minimize disease progression and death. The overarching goal of the PPHOR SWG is to seed and catalyze research collaborations between Einstein, Rockefeller, and CUNY investigators that impact both patient and population health. The SWG will fully leverage and enhance interdisciplinary research collaborations related to the PPHOR SWG's overarching aims by providing infrastructure for and bringing together the Public Health/Implementation Science researchers at CUNY, behavioral, epidemiological and clinical researchers at Einstein, basic science and clinical researchers at Rockefeller, and public health professionals from the NYC DOHMH and NYS DOH. These collaborations will result in new ways to improve HIV prevention and care continuum outcomes by augmenting ongoing collaborations between the three academic institutions, and will occur in three main realms: 

  1. Preventing HIV acquisition through identifying and evaluating approaches to increase uptake of nPEP/PrEP
  2. Preventing HIV-associated morbidity and mortality through earlier diagnosis and treatment initiation
  3. Preventing onward transmission of HIV through sustained viral suppression

For further information or to join this SWG and participate in the meetings, please contact either Dr. Denis Nash or Dr. Julia Arnsten.

Dr. Denis Nash
Professor, CUNY School of Public Health
Executive Director, CUNY Institute for Implementation Science in Population Health 

Dr. Julia Arnsten
Professor, Medicine Chief, Division of General Internal Medicine, Einstein 
Director, Center for Comparative Effectiveness Research


Einstein Logo 

Rockefeller Logo 

CUNY Logo 


ERC-CFAR at a Glance

Partner Institutions 

  • Albert Einstein College of Medicine
  • Rockefeller University
  • The City University of New York (CUNY)


Total ERC-CFAR members

  • 183 Full members
  • 10 Affiliate members

CFAR member trainees funded by NIH K awards

  • 15 Full members

NIH Funding 

FY2015 OAR NIH AIDS FRB grants

$34,084,840 Total costs


New NIH AIDS grants awarded in FY2016

$7,345,645 Total annual costs


FY2014 non-AIDS NIH grants

$34,745,334 Total costs

Publications (first 6 months of 2016) 

Total Publications: 240

Publications multi-authored
by ERC-CFAR members: 91



Director: Dr. H. Goldstein



Directors: Dr. V. Prasad & Dr. C. Cunningham


Biomarkers & Advanced Technologies 

Directors: Dr. J. Berman & Dr. S. Almo


Behavioral Science 

Director: Dr. L. Bauman


Clinical Translational Implementation Science 

Director: Dr. K. Anastos


Scientific Working Groups 

HIV and Eradication 

Directors: Dr. G. Kalpana & Dr. M. Caskey


Patient and Population Health Outcomes Research 

Directors: Dr. D. Nash & Dr. J. Arnsten  

New 2016 NIH Grants Awards 

Click here to log in

In the Media

Can an Immune Strategy Used to Treat Cancer Also Wipe Out HIV Infections?

Harris Goldstein, M.D., describes his new research, in Science Translational Medicine, that uses genetically reprogrammed T cells to successfully fight HIV infection in mice. Dr. Goldstein is professor of pediatrics and of microbiology & immunology and director of the Einstein-Rockefeller-CUNY Center for AIDS Research.

(Thursday, Aug 08, 2019)

Trump's HIV Plan Met With Both Cautious Optimism, Flat-Out Skepticism

Harris Goldstein, M.D., says he is encouraged by the prospect of increased federal funds for regional AIDS research centers that help advance treatments and improve health outcomes. Dr. Goldstein is director of the Einstein-Rockefeller-CUNY Center for AIDS Research and an attending physician at Children’s Hospital at Montefiore.

(Tuesday, Feb 12, 2019)

coverage on other stories